MEITHEAL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has seventy-eight approved drugs.
Summary for MEITHEAL
| US Patents: | 0 |
| Tradenames: | 65 |
| Ingredients: | 64 |
| NDAs: | 78 |
Drugs and US Patents for MEITHEAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meitheal | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077425-002 | Aug 29, 2013 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meitheal | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 212960-001 | May 28, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meitheal | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 213463-001 | Nov 13, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
